Neurotrophic Keratitis: Early Detection and Intervention for Enhanced Outcomes
This activity is supported by an educational grant from Dompé US, Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Dompé US, Inc.
Activity Description
Neurotrophic keratitis (NK) is a degenerative corneal disease that, if left undiagnosed and untreated, can lead to corneal ulceration, stromal melting, and vision loss. Therefore, an accurate diagnosis of NK in the early stages of the disease is essential but can be challenging if the patient is experiencing few symptoms. Decreased or loss of corneal sensitivity is the hallmark of NK, and all patients with suspected NK should undergo corneal sensitivity testing. Current and emerging treatment options can restore corneal sensitivity, promote healing, and stop disease progression when integrated into management protocols. In this CE activity, experts in the field discuss both evidence-based modalities, including corneal sensitivity testing, and interprofessional strategies for the early detection and differentiation of NK from other ocular disorders. They also evaluate current and emerging therapies for the treatment of NK based on the stage of disease.
Target Audience
The intended audience for this activity is comprehensive ophthalmologists, optometrists, and other healthcare professionals involved in the management of patients with NK.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Employ evidence-based modalities including corneal sensitivity testing and interprofessional strategies for the early detection and differentiation of NK from other ocular surface disorders.
- Apply current and emerging therapies for the treatment of NK based on the stage of the disease.
Activity Chair
Elizabeth Yeu, MD
Cornea, Cataract, External Disease and Refractive Surgery
Virginia Eye Consultants/EyeCare Partners
Medical Director, CVP Mid-Atlantic Surgery Center
Assistant Professor, Eastern Virginia Medical School
President, American Society of Cataract and Refractive Surgery (ASCRS)
Norfolk, VA
Faculty
Brandon D. Ayres, MD
Cornea Service
Co-Director of Cornea Fellowship
Wills Eye Hospital
Philadelphia, PA
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Walter O. Whitley, OD, MBA, FAAO
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity will also award credit for optometry (COPE) if the requirements necessary for credit are met.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education designates this enduring material for a maximum of 0.75 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
COPE Course ID: 88614-TD
COPE Activity ID: 127336
This enduring material is approved for 1 year from the date of original release, November 30, 2023, to November 29, 2024.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate or COPE CE certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Brandon D. Ayres, MD
Consultant: Alcon, Allergan, Bausch + Lomb, Dompé, Expert Opinion, Glaukos, Gore Surgical, MicroSurgical Technology, Mojo, Novartis, Rayner, Sight Sciences, Sun, Tarsus, Trukera Medical, Zeiss
Speaker Contracted by Ineligible Company: Allergan, Dompé, Sun
Elizabeth Yeu, MD
Consultant: AbbVie, AcuFocus, Advanced Vision, Aldeyra, Allergan, Aurion, Avellino, Bausch + Lomb, BioTissue, BlephEx, Bruder, BVI, CorneaGen, Dompé, Elios, Expert Opinion, Eyenovia, Glaukos, Guidepoint, IVERIC Bio, Johnson & Johnson Vision, Kala, LayerBio, Lensar, Melt, Merck, New World Medical, Novartis, Ocular Science, OCuSOFT, Samsara, ScienceBased Health, Sight Sciences, STAAR, Surface, Tarsus, Théa, Visus, Zeiss
Speaker Contracted by Ineligible Company: Alcon
Independent Research Contractor: AcuFocus, Alcon, BioTissue, New World Medical, Ocular Science, Tarsus
Individual Stocks and Stock Options: Advanced Vision, Aurion, Avellino, BlephEx, Centricity, CorneaGen, Equinox, Expert Opinion, Layer Bio, Mati, Melt, Modernizing Medicine, Ocular Science, Orasis, STAAR, Tarsus, Visus
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Walter O. Whitley, OD, MBA, FAAO
Consultant: Alcon, Aldeyra, Allergan, Azura, Bausch + Lomb, Bruder, Dompé, Heru, IVERIC Bio, Kala, Lumenis, Ocuphire, Oyster Point, ScienceBased Health, Sight Sciences, Sun, Tarsus, Thea Pharma, Visus, Zeiss
Speaker Contracted by Ineligible Company: Alcon, Allergan, Bausch + Lomb, Dompé, Kala, Oyster Point, Sun, Tarsus
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this lecture is available upon request. Requests should include the activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com